Browse by author
Lookup NU author(s): Dr David Crossland,
Professor Sir John BurnORCiD,
Dr John O'Sullivan
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Objective: To compare the outcome of life insurance and mortgage applications of adults with congenital heart disease (CHD) with controls and at different severities of CHD. Methods: Two hundred and ninety-nine adult CHD patients underwent a questionnaire-based interview by a trained nurse. They were asked to give an identical questionnaire to a friend to act as a control. One hundred and seventy-seven controls replied. CHD patients were classified into three categories based on severity. Comparisons were made between matched controls and between different severities of CHD. Results: Similar proportions of the CHD group (59%) had applied for life insurance as matched controls (56%). Compared to controls, significantly more of the adults with CHD who had applied for life insurance have been refused (34 vs 4%, P<0.0001) or asked to pay extra (37 vs 6%, P=0.0002). Mortgage application rate was also similar in both groups with more of the CHD patients refused than matched controls (20 vs 3%, P=0.004). These differences in both life insurance and mortgage remain significant when the cases and controls are matched by employment status and NYHA functional class. There was no significant difference in life insurance and mortgage application outcome between the groups of mild, significant and complex CHD. Conclusions: Adults with CHD are significantly more likely to have difficulty obtaining life insurance or a mortgage than controls. Refusal rates appear to be independent of the severity of CHD. This suggests that the label of CHD may have a negative impact despite the lesion being minor and that the outcome of an individual application is difficult to predict based on the severity of the CHD. The increasing numbers of adults with CHD suggest that this problem is likely to increase and needs to be addressed as it can have a major impact on the patient's quality of life. © 2004 Elsevier B.V. All rights reserved.
Author(s): Crossland DS, Jackson SP, Lyall R, Hamilton JRL, Hasan A, Burn J, O'Sullivan JJ
Publication type: Article
Publication status: Published
Journal: European Journal of Cardio-Thoracic Surgery
ISSN (print): 1010-7940
ISSN (electronic): 1873-734X
Publisher: Elsevier BV
PubMed id: 15144990
Altmetrics provided by Altmetric